Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 9.092% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) Cc1ccc(CNC(=O)C2CCN(S(=O)(=O)c3c(C)noc3C)CC2)cc1
(b) CCOCCCNC(=S)NCCCNc1nc2ccc(C)cc2cc1C#N
(c) COC(=O)c1ccc(N2CN=C(c3ccc(C)cc3)NC2=S)cc1
(d) COc1cc2c(cc1OC)CN(C(=O)/C=C/c1ccc([N+](=O)[O-])cc1)CC2
(e) CC1=CC(C)C2(COC(=O)Nc3ccccc3)COC(C)C1C2C
Answer: c. COC(=O)c1ccc(N2CN=C(c3ccc(C)cc3)NC2=S)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(N2CN=C(c3ccc(C)cc3)NC2=S)cc1
COC(=O)c1ccc(N2CN=C(c3ccc(C)cc3)NC2=S)cc1
methyl 4-[6-(4-methylphenyl)-2-sulfanylidene-1,4-dihydro-1,3,5-triazin-3-yl]benzoate